Indefinite Delivery Contract SPE2DX15D9202

The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $4,999,999.00 IDC, valid through December 2025, enables the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and various medical consumables. The contract covers an extensive portfolio of pharmaceutical items across multiple therapeutic categories, positioning DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain. The delivery orders, which do not have any set-aside designations, are issued from the DLA's Philadelphia-based medical supply chain operations, with the place of performance being DMS Pharmaceutical Group's facility in Park Ridge, Illinois.

The task orders awarded under this IDC demonstrate DMS Pharmaceutical Group's ability to fulfill a diverse range of pharmaceutical requirements for the Department of Defense, including specialized medications such as Xolair, Trikafta, Keytruda, Botox, and Nucala. The firm fixed-price delivery orders, valued from hundreds to hundreds of thousands of dollars, cover a wide spectrum of medical needs, including oncology treatments, contraceptives, auto-injectors, and other specialized pharmaceutical products. This IDC reinforces DMS Pharmaceutical Group's position as a trusted and capable supplier of pharmaceuticals and medical supplies to the federal government's military healthcare system.